THU0302 Survival of disease-modifying drugs (DMARD) in patients with recent diagnosis of psoriatic arthritis in daily clinical practice

D. FreitesLeticia LeónZulema RosalesJ. FontCristina LajasEsperanza PatoLuis Rodríguez‐RodríguezBenjamín Fernández‐GutiérrezJuan Ángel JoverLydia Abásolo2026-03-222026-03-22201810.1136/annrheumdis-2018-eular.2508https://doi.org/10.1136/annrheumdis-2018-eular.2508https://andeanlibrary.org/handle/123456789/67162enMedicinePsoriatic arthritisDiseaseClinical PracticeInternal medicinePsoriasisDermatologyIntensive care medicineTHU0302 Survival of disease-modifying drugs (DMARD) in patients with recent diagnosis of psoriatic arthritis in daily clinical practicearticle